Cipla, Hetero Labs secure DCGI nod for Remdesivir to treat COVID cases Ruchika Sharma22 Jun 2020 11:01 AM ISTThe drug, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.
COVID-19 Treatment: Glenmark gets DCGI nod to launch oral antiviral drug favipiravir Ruchika Sharma20 Jun 2020 11:44 AM ISTNew Delhi: Drug firm Glenmark Pharmaceuticals on Friday said it has received approval from the Indian drug regulator to launch oral antiviral drug...
CSIR gets DCGI nod for Phase III Clinical Trial of Umifenovir in COVID-19 Ruchika Sharma19 Jun 2020 11:13 AM ISTUmifenovir is mainly used for the treatment of influenza and is available in China and Russia, and has recently come into prominence due to its...
Defective COVID Test Kits: Licence for Chinese kits issued only after validation, DCGI tells court Farhat Nasim16 Jun 2020 4:52 PM ISTThe court was further informed via a counter affidavit by the Indian Council of Medical Research (ICMR) that clarified that the kits of Guangzhou...
Bharat Serums gets DCGI nod to test sepsis drug on Covid-19 patients Ruchika Sharma10 Jun 2020 1:37 PM ISTBharat Serums and Vaccines Ltd (BSVL) has received approval from the Drug Controller General of India (DCGI) to conduct phase-III clinical study on...
DCGI-ICMR Guidelines: Manufacturer, supplier of COVID-19 diagnostic kits can directly apply for DCGI approval, Details Ruchika Sharma9 Jun 2020 4:09 PM ISTAs per the guidelines, the manufacturers and suppliers of US Food and Drug Administration (USFDA) approved RT-PCR kits, RNA extraction kits and viral...
Sun Pharma dengue drug AQCH enters Phase 2 clinical trial for COVID-19 treatment Ruchika Sharma5 Jun 2020 5:17 PM ISTAQCH, which is being developed for dengue, has shown a broad antiviral effect in vitro studies and hence is being tested as a potential treatment...
Sun Pharma gets DCGI nod to initiate clinical trial with Nafamostat in Covid-19 patients Ruchika Sharma30 May 2020 10:22 AM ISTNafamostat is approved in Japan for the improvement of acute symptoms of pancreatitis and the treatment of Disseminated Intravascular Coagulation...
Biocon Biologics gets DCGI nod for use of CytoSorb in critical COVID-19 cases Hina Zahid28 May 2020 2:13 PM ISTBiopharmaceutical company Biocon on Wednesday announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India's...
Cipla, Hetero approach DCGI seeking waiver of Clinical Trial of Remdesivir in India: Report MD Bureau25 May 2020 4:59 PM ISTNew Delhi: With pharma companies across the country making efforts to get the first-mover advantage in bringing potential coronavirus treatments, two...
Gilead holds talks with Health Ministry, DCGI officials to bring Remdesivir to India Ruchika Sharma23 May 2020 12:00 PM ISTThe medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) to treat hospitalised...
COVID-19: Strides Pharma gets DCGI nod to conduct favipiravir trials in India Ruchika Sharma22 May 2020 12:00 PM ISTFavipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in...
